Gene · 57823
Papers3,217
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,217
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nanoscale restructuring of the immune synapse with an engager enhances NK cell function. | Proc Natl Acad Sci U S A | 2025 | 40966288 | PubTator, text mining | PubMed |
| Elucidation of hub cross-talk genes as potential biomarkers and drug prediction for chronic periodontitis and rheumatoid arthritis: A bioinformatics analysis. | Medicine (Baltimore) | 2025 | 40958328 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing analysis reveals a novel porcine alveolar macrophage subtype with high SLAMF7 expression promoting PRRSV infection. | Virulence | 2025 | 40944943 | PubTator, text mining | PubMed |
| AI-informed retinal biomarkers predict 10-year risk of onset of multiple hematological malignancies. | Eur J Cancer | 2025 | 40925094 | PubTator, text mining | PubMed |
| Divergent on-target off-tumor effects by CAR T and CAR NK cells suggest different efficacy and safety of cell therapies. | Oncoimmunology | 2025 | 40910564 | PubTator, text mining | PubMed |
| SLAMF7 (CD319) enhances cytotoxic T-cell differentiation and sensitizes CD8+ T cells to immune checkpoint blockade. | Front Immunol | 2025 | 40909279 | PubTator, text mining | PubMed |
| Corrigendum to SLAMF7 and SLAMF8 receptors shape human plasmacytoid dendritic cell responses to intracellular bacteria. | J Clin Invest | 2025 | 40892522 | PubTator, text mining | PubMed |
| The instrumental role of lipids in governing the sensitivity of multiple myeloma to ferroptosis. | Discov Oncol | 2025 | 40853521 | PubTator, text mining | PubMed |
| Advancements and challenges in CAR-T cell therapy for solid tumors: A comprehensive review of antigen targets, strategies, and future directions. | Cancer Cell Int | 2025 | 40849468 | PubTator, text mining | PubMed |
| Therapeutic options for extramedullary involvement in multiple myeloma. | Clin Exp Med | 2025 | 40849366 | PubTator, text mining | PubMed |
| A case report of IgG4-RD involving bilateral renal pelvis and literature review. | Medicine (Baltimore) | 2025 | 40826696 | PubTator, text mining | PubMed |
| Dual targeting of BCMA and SLAMF7 with the CARtein system: chimeric antigen receptors with intein-mediated splicing elicit specific T cell activation against multiple myeloma. | Front Immunol | 2025 | 40821776 | PubTator, text mining | PubMed |
| Direct visualization of chimeric antigen receptors on primary human T cells using dSTORM super-resolution microscopy. | Front Immunol | 2025 | 40821773 | PubTator, text mining | PubMed |
| CyTOF profiling of bone marrow immune dynamics across myeloma stages. | Oncoimmunology | 2025 | 40820826 | PubTator, text mining | PubMed |
| Targeting degradation of IKZF1 and IKZF3 through modulation of the E3 ligase substrates in the context of cellular therapies for multiple myeloma. | Biomark Res | 2025 | 40817326 | PubTator, text mining | PubMed |
| 3D Tumor microenvironment interaction reveals AP-1 complex regulation and contact-mediated reprogramming of bone marrow stromal cells in chronic lymphocytic leukemia. | Hemasphere | 2025 | 40809351 | PubTator, text mining | PubMed |
| Multimodal profiling reveals tissue-directed signatures of human immune cells altered with age. | Nat Immunol | 2025 | 40804529 | PubTator, text mining | PubMed |
| Targeted Proteomic Analysis of Sickle Cell Disease Patients With Elevated Tricuspid Regurgitation Velocity. | Proteomics Clin Appl | 2025 | 40785364 | PubTator, text mining | PubMed |
| Genetics of progressive multifocal leukoencephalopathy: update on case reports with an inborn error of immunity and risk variants found in drug-linked cases. | Front Neurol | 2025 | 40761639 | PubTator, text mining | PubMed |
| ApoBDs: a paradigm shift from cellular debris to therapeutic vehicles. | Front Endocrinol (Lausanne) | 2025 | 40747304 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57823/papers?page=4